MELD Score Calculator
Calculate your Model for End-Stage Liver Disease (MELD) score to assess liver transplant urgency
Introduction & Importance of MELD Score
The Model for End-Stage Liver Disease (MELD) score is a numerical scale ranging from 6 to 40 that measures the severity of chronic liver disease. Developed in 2000 and adopted by UNOS (United Network for Organ Sharing) in 2002, the MELD score has become the standard for determining liver transplant allocation priority in the United States and many other countries.
Why the MELD Score Matters
- Transplant Prioritization: Patients with higher MELD scores (typically ≥15) receive higher priority for liver transplants as they have greater 3-month mortality risk without transplantation.
- Prognostic Tool: The score predicts 90-day mortality risk in patients with liver cirrhosis, helping clinicians make informed treatment decisions.
- Standardized Assessment: Provides an objective, laboratory-based measurement that reduces subjectivity in organ allocation.
- Treatment Guidance: Helps determine when patients should be referred for transplant evaluation or listed for transplantation.
According to the Organ Procurement and Transplantation Network (OPTN), over 8,000 liver transplants are performed annually in the U.S., with MELD scores playing a crucial role in organ distribution.
How to Use This MELD Score Calculator
Our interactive calculator provides an accurate MELD score based on the most current UNOS methodology. Follow these steps for precise results:
- Gather Laboratory Values: Obtain your most recent blood test results for bilirubin, INR, creatinine, and sodium levels. Values should be from the same day for maximum accuracy.
- Enter Bilirubin Level: Input your total bilirubin in mg/dL (normal range: 0.3-1.2 mg/dL). For values >4.0 mg/dL, the calculator automatically caps at 4.0 as per MELD guidelines.
- Input INR Value: Enter your International Normalized Ratio (normal range: 0.8-1.2). The calculator caps INR at 8.0 for calculation purposes.
- Provide Creatinine: Input your serum creatinine in mg/dL (normal range: 0.6-1.2 mg/dL for males, 0.5-1.1 mg/dL for females). The calculator caps creatinine at 4.0 mg/dL.
- Select Dialysis Status: Choose your dialysis status from the dropdown menu. Patients on dialysis receive additional points in the calculation.
- Add Sodium Level: Enter your serum sodium in mEq/L (normal range: 135-145 mEq/L). This was added to the MELD score in 2016 (MELD-Na).
- Calculate Your Score: Click the “Calculate MELD Score” button to receive your results and interpretation.
Important Note: This calculator provides an estimate based on the inputs provided. For official medical evaluation, always consult with your healthcare provider. The calculator follows the standard MELD formula published in the Journal of Hepatology.
MELD Score Formula & Methodology
The MELD score is calculated using a complex logarithmic formula that incorporates three primary laboratory values. In 2016, sodium was incorporated (MELD-Na) to improve predictive accuracy.
Original MELD Formula (2002-2016):
MELD = 3.78 × ln[serum bilirubin (mg/dL)] + 11.2 × ln[INR] + 9.57 × ln[serum creatinine (mg/dL)] + 6.43
Current MELD-Na Formula (2016-Present):
MELD-Na = MELD + 1.32 × (137 – Na) – [0.033 × MELD × (137 – Na)]
Key Components:
- Bilirubin: Measures liver’s ability to process waste. Higher values indicate worse liver function.
- INR: International Normalized Ratio measures blood clotting ability. Higher values indicate reduced liver function.
- Creatinine: Measures kidney function, which is often impaired in advanced liver disease.
- Sodium: Added in 2016 to account for hyponatremia, which predicts mortality independent of MELD.
- Dialysis Adjustment: Patients on dialysis receive additional points due to increased mortality risk.
Value Capping Rules:
| Laboratory Value | Minimum Value | Maximum Value | Rationale |
|---|---|---|---|
| Bilirubin (mg/dL) | 1.0 | 4.0 | Values beyond these have diminishing returns in mortality prediction |
| INR | 1.0 | 8.0 | Higher INR values don’t linearly increase mortality risk |
| Creatinine (mg/dL) | 1.0 | 4.0 | Account for maximum renal dysfunction impact |
| Sodium (mEq/L) | 120 | 137 | Hyponatremia correction factors |
The MELD score is rounded to the nearest integer and ranges from 6 (least severe) to 40 (most severe). Scores are updated regularly based on current laboratory values to reflect the patient’s changing condition.
Real-World MELD Score Examples
Understanding how different laboratory values translate to MELD scores can help patients and clinicians interpret results. Below are three detailed case studies:
Case Study 1: Early-Stage Cirrhosis
| Patient Profile: | 52-year-old male with compensated cirrhosis due to NASH |
| Bilirubin: | 1.8 mg/dL |
| INR: | 1.3 |
| Creatinine: | 0.9 mg/dL |
| Sodium: | 138 mEq/L |
| Dialysis: | None |
| MELD Score: | 9 |
| Interpretation: | Low risk of 3-month mortality (1.9%). Transplant not currently indicated. Focus on managing underlying liver disease and preventing progression. |
Case Study 2: Decompensated Cirrhosis
| Patient Profile: | 47-year-old female with alcohol-related cirrhosis and ascites |
| Bilirubin: | 5.2 mg/dL (capped at 4.0) |
| INR: | 2.1 |
| Creatinine: | 1.8 mg/dL |
| Sodium: | 132 mEq/L |
| Dialysis: | None |
| MELD Score: | 22 |
| Interpretation: | Moderate risk of 3-month mortality (19.6%). Patient should be evaluated for transplant listing. Consider TIPS procedure for portal hypertension management. |
Case Study 3: End-Stage Liver Disease
| Patient Profile: | 61-year-old male with HCV cirrhosis, hepatic encephalopathy, and hepatorenal syndrome |
| Bilirubin: | 12.4 mg/dL (capped at 4.0) |
| INR: | 3.5 |
| Creatinine: | 3.2 mg/dL |
| Sodium: | 128 mEq/L |
| Dialysis: | 2x in last week |
| MELD Score: | 35 |
| Interpretation: | High risk of 3-month mortality (82.7%). Urgent transplant evaluation required. Patient should be listed at a transplant center immediately. Consider living donor options if available. |
MELD Score Data & Statistics
The MELD score system has been extensively studied since its implementation. Below are key statistics and comparative data:
3-Month Mortality Risk by MELD Score
| MELD Score Range | 3-Month Mortality Risk | Transplant Priority | Typical Clinical Scenario |
|---|---|---|---|
| <9 | 1.9% | Low | Compensated cirrhosis, minimal symptoms |
| 10-19 | 6.0% | Low-Moderate | Early decompensation, varices, ascites |
| 20-29 | 19.6% | Moderate-High | Recurrent variceal bleeding, refractory ascites |
| 30-39 | 52.6% | High | Hepatorenal syndrome, hepatic encephalopathy |
| ≥40 | 71.3% | Urgent | Multi-organ failure, imminent death without transplant |
Transplant Waitlist Outcomes by MELD Score (2022 Data)
| MELD Score at Listing | Median Wait Time (days) | Transplant Rate | Waitlist Mortality | Post-Transplant 1-Year Survival |
|---|---|---|---|---|
| <15 | 365+ | 42% | 5% | 95% |
| 15-24 | 180-270 | 68% | 12% | 92% |
| 25-34 | 90-120 | 85% | 22% | 88% |
| ≥35 | <30 | 92% | 38% | 85% |
Data sources: OPTN/SRTR Annual Data Report and Journal of Hepatology MELD studies.
MELD Score Distribution in U.S. (2023)
As of 2023, there are approximately 11,000 patients on the liver transplant waitlist in the United States. The distribution of MELD scores among waitlisted patients is as follows:
- MELD <15: 28% of waitlisted patients (typically wait 1+ years)
- MELD 15-24: 42% of waitlisted patients (median wait 6-12 months)
- MELD 25-34: 22% of waitlisted patients (median wait 3-6 months)
- MELD ≥35: 8% of waitlisted patients (transplanted within weeks)
Expert Tips for Managing Your MELD Score
While the MELD score is primarily used for transplant prioritization, there are strategies patients can employ to potentially improve their score and overall health:
Lifestyle Modifications
- Sodium Restriction: Limit sodium intake to <2000 mg/day to manage ascites and improve sodium levels in your MELD-Na score.
- Fluid Management: Restrict fluids to 1.5-2L/day if you have hyponatremia (sodium <135 mEq/L).
- Alcohol Cessation: Complete abstinence from alcohol is essential for alcoholic liver disease. Even small amounts can worsen liver function.
- Protein Intake: Consume 1.2-1.5g/kg of high-quality protein daily unless you have hepatic encephalopathy.
- Exercise: Engage in light to moderate physical activity (walking, swimming) to maintain muscle mass and overall health.
Medical Management Strategies
- Lactulose for HE: Proper use of lactulose can prevent hepatic encephalopathy episodes that might increase your MELD score.
- Diuretics: Work with your doctor to optimize diuretic therapy (spironolactone + furosemide) to manage ascites without worsening kidney function.
- Beta Blockers: For portal hypertension, non-selective beta blockers (propranolol, nadolol) can reduce variceal bleeding risk.
- Vaccinations: Stay current with pneumococcal, influenza, and hepatitis vaccines to prevent infections that could worsen liver function.
- TIPS Procedure: For patients with recurrent variceal bleeding or refractory ascites, a TIPS procedure may improve quality of life and potentially stabilize MELD score.
Transplant Preparation Tips
- Early Referral: Get referred to a transplant center when your MELD score reaches 15-18 to complete evaluation before your score gets too high.
- Living Donor: Explore living donor options which can significantly reduce wait times regardless of your MELD score.
- Multiple Listings: Consider getting listed at multiple transplant centers to increase your chances of receiving an organ.
- Exception Points: Work with your doctor to apply for MELD exception points if you have conditions like hepatocellular carcinoma that aren’t fully captured by the MELD score.
- Support System: Build a strong support system of family/friends who can help with the transplant process and recovery.
Important Warning: Never attempt to manipulate your MELD score by dehydrating yourself or skipping medications. This can be dangerous and transplant centers have safeguards to detect such behaviors. Always follow your doctor’s advice for managing your liver disease.
Interactive FAQ About MELD Scores
How often should my MELD score be recalculated?
Your MELD score should be recalculated whenever there’s a significant change in your clinical status or at least every 3 months while you’re on the transplant waitlist. The United Network for Organ Sharing (UNOS) requires MELD score updates:
- Every 3 months for scores <25
- Every month for scores 25-34
- Every week for scores ≥35
More frequent updates may be required if you’re hospitalized or experience clinical decompensation events like variceal bleeding or hepatic encephalopathy.
Can my MELD score go down? What does that mean?
Yes, your MELD score can decrease if your liver function improves. This typically happens when:
- Underlying liver disease is successfully treated (e.g., antiviral therapy for hepatitis C)
- Alcohol cessation in alcoholic liver disease leads to liver recovery
- Ascites and other complications are effectively managed
- Infections or other acute issues resolve
A decreasing MELD score generally indicates improving liver function, which is positive. However, if your score was high enough to qualify for transplant listing, a significant drop might affect your priority. Your transplant team will monitor this carefully and may temporarily inactive you on the waitlist if your score drops below a certain threshold (typically 15-18).
How does dialysis affect my MELD score?
Dialysis has a significant impact on your MELD score calculation:
- No dialysis: Your creatinine value is used directly in the calculation (capped at 4.0 mg/dL)
- Dialysis 2x in last week: Your creatinine is automatically set to 4.0 mg/dL in the calculation, regardless of your actual value
- Dialysis ≥2x in last week: Same as above, plus you receive additional points for being on dialysis
The dialysis adjustment reflects the increased mortality risk for patients with both liver and kidney failure. Patients on dialysis typically have higher MELD scores and thus higher transplant priority.
What’s the difference between MELD and MELD-Na scores?
The original MELD score (implemented in 2002) used only bilirubin, INR, and creatinine. In 2016, sodium was incorporated to create the MELD-Na score:
| Feature | Original MELD | MELD-Na |
|---|---|---|
| Components | Bilirubin, INR, Creatinine | Bilirubin, INR, Creatinine, Sodium |
| Sodium Impact | Not included | Lower sodium increases score |
| Predictive Accuracy | Good | 10-15% better for 90-day mortality |
| Implementation Date | 2002 | 2016 |
| Current Usage | No longer used | Standard for all liver transplant allocations |
The MELD-Na score better predicts mortality because hyponatremia (low sodium) is an independent predictor of death in cirrhosis patients. The sodium adjustment can increase a patient’s score by 1-5 points depending on their sodium level.
At what MELD score do most patients get transplanted?
The MELD score at which patients typically receive a transplant varies by region and blood type, but national data shows:
- Blood Type O: Median transplant MELD is 28-32 (highest due to organ shortage)
- Blood Type A: Median transplant MELD is 25-29
- Blood Type B: Median transplant MELD is 22-26
- Blood Type AB: Median transplant MELD is 20-24 (lowest due to universal recipient status)
About 50% of liver transplants occur at MELD scores between 25-34. Patients with MELD scores ≥35 typically receive transplants within weeks due to their high mortality risk without transplantation.
Note that exceptions exist for conditions like hepatocellular carcinoma (HCC) where patients may receive additional MELD points to reflect their urgency without having extremely high laboratory MELD scores.
How does pediatric liver transplantation differ from adult MELD scoring?
Children under 12 years old use a different scoring system called PELD (Pediatric End-Stage Liver Disease) which accounts for growth failure and other pediatric-specific factors:
| Feature | MELD (Adults) | PELD (Children <12) |
|---|---|---|
| Age Group | 12+ years | <12 years |
| Components | Bilirubin, INR, Creatinine, Sodium | Bilirubin, INR, Albumin, Growth Failure, Age <1 year |
| Score Range | 6-40 | -10 to +30 |
| Key Differences | Focus on mortality risk | Includes growth failure and nutritional status |
| Implementation | 2002 (updated 2016) | 2002 |
Children 12 and older use the standard MELD score. The PELD score was developed because creatinine levels (used in MELD) are naturally lower in children, and growth failure is a critical indicator of liver disease severity in pediatric patients.
What happens if my MELD score is too low for transplant but I’m very sick?
If your MELD score doesn’t reflect your clinical severity, you may qualify for a MELD exception. Common scenarios include:
- Hepatocellular Carcinoma (HCC): Automatic exception points based on tumor size/number (22 points for T1, 28 for T2)
- Hepatopulmonary Syndrome: Can receive exception points based on oxygenation levels
- Portopulmonary Hypertension: May qualify for additional points based on mean pulmonary artery pressure
- Familial Amyloidosis: Automatic listing at MELD 22 after 6 months of listing
- Primary Oxaluria: Automatic listing at MELD 28
To apply for an exception:
- Your transplant center submits a request to the regional review board
- You must provide documentation proving your condition meets exception criteria
- The review board evaluates your case (process takes 2-4 weeks)
- If approved, you receive additional MELD points
Exception points are typically granted for 30-90 days and must be renewed. Your transplant team can guide you through this process.